GSK and Theravance Announce Regulatory Submission for ANOROâ„¢ ELLIPTAâ„¢ (UMEC/VI) in Japan

[at noodls] – LONDON and SOUTH SAN FRANCISCO, CA–(Marketwired – Apr 22, 2013) – GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a regulatory application to the Japanese … more

View todays social media effects on THRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Theravance is hiring next, click here to view